PEOPLE - Calypte Biomedical (US) makes appointment:
This article was originally published in Clinica
Calypte Biomedical (Alameda, California), a developer and marketer of urine-based diagnostic products and services, has appointed scientists Richard George and Ronald Mink to lead the company's development of rapid assays for the detection of HIV antibodies. Dr George most recently served as senior vice-president at OraSure Technologies and is a 30-year veteran of the Centers for Disease Control and Prevention. Dr Mink, who most recently served as director of R&D at OraSure, is the inventor of the first OraQuick HIV-1 rapid prototypes.